Literature DB >> 2459238

Structural and functional studies of HLA-DR restricted antigen recognition by human helper T lymphocyte clones by using transfected murine cell lines.

R I Lechler1, V Bal, J B Rothbard, R N Germain, R Sekaly, E O Long, J Lamb.   

Abstract

Murine L cells expressing the products of transfected HLA-DR1 genes functioned as APC for two influenza-specific, human Th cell clones with comparable efficiency to a DR1-expressing human lymphoblastoid cell line. In order to investigate the restriction specificity of the two Th clones, a transfectant expressing the species-mismatched MHC class II dimer DR1:I-E was tested as an APC. Both T cells showed no loss of Ag sensitivity due to substitution of the murine chain. One of the Th clones, TLC 72, showed even greater degeneracy by responding to Ag in the context of I-Ek. Taking into account the lower level of MHC class II expression on the I-Ek transfectant, there is remarkably little loss of efficiency of Ag-induced T cell activation due to the substitution of I-E for DR as restriction element. The Ag-specific responses of both clones were inhibited by anti-CD4 antibody when DR-transfected L cells or human lymphoblastoid cells were used as APC. This inhibition was also seen when Ag was presented to TLC72 by the I-Ek-expressing transfectant. Whether this inhibition is the result of negative signaling or of blocking an interaction between human CD4 and I-Ek is discussed. Similarly the inhibitory effects of mAb against the T cell accessory molecule LFA/1 were the same for both clones when either the transfectants or the lymphoblastoid cell line were used as APC, suggesting that L cells may express a molecule that is capable of acting as a ligand for human LFA/1. The results presented here further illustrate the value of transfectants in analyzing T cell recognition and accessory cell requirements. The patterns of degeneracy of MHC restriction exhibited by these clones provides a platform for a more detailed analysis of key residues involved in MHC class II-restricted T cell Ag recognition.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2459238

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  Interactions between immunogenic peptides and HLA-DR molecules.

Authors:  J B Rothbard; R Busch
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

2.  Allorecognition of DR1 by T cells from a DR4/DRw13 responder mimics self-restricted recognition of endogenous peptides.

Authors:  G Lombardi; S Sidhu; J R Batchelor; R I Lechler
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

3.  Shared promoter elements between a viral superantigen and the major histocompatibility complex class II-associated invariant chain.

Authors:  J Arroyo; E Winchester; B S McLellan; B T Huber
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

4.  Co-operation between human CR1 (CD35) and CR2 (CD21) in internalization of their C3b and iC3b ligands by murine-transfected fibroblasts.

Authors:  M L Grattone; C L Villiers; M B Villiers; C Drouet; P N Marche
Journal:  Immunology       Date:  1999-09       Impact factor: 7.397

5.  A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general population.

Authors:  Denise M McKinney; Scott Southwood; Denise Hinz; Carla Oseroff; Cecilia S Lindestam Arlehamn; Veronique Schulten; Randy Taplitz; David Broide; Willem A Hanekom; Thomas J Scriba; Robert Wood; Rafeul Alam; Bjoern Peters; John Sidney; Alessandro Sette
Journal:  Immunogenetics       Date:  2013-02-08       Impact factor: 2.846

6.  Generation and characterization of an HLA-DR alpha-specific monoclonal antibody using L-cell transfectants expressing human and mouse class II major histocompatibility dimers.

Authors:  D Palmer; M Kevany; C Mackworth-Young; R Batchelor; G Lombardi; R Lechler
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

7.  Signaling efficiency of the T cell receptor controlled by a single amino acid in the beta chain constant region.

Authors:  B T Bäckström; B T Hausmann; E Palmer
Journal:  J Exp Med       Date:  1997-12-01       Impact factor: 14.307

8.  Highly biased CDR3 usage in restricted sets of beta chain variable regions during viral superantigen 9 response.

Authors:  C Ciurli; D N Posnett; R P Sékaly; F Denis
Journal:  J Exp Med       Date:  1998-01-19       Impact factor: 14.307

9.  Major histocompatibility complex class II-restricted antigen presentation across a species barrier: conservation of restriction determinants in evolution.

Authors:  R E Bontrop; D G Elferink; N Otting; M Jonker; R R de Vries
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

10.  Human T cells cannot act as autonomous antigen-presenting cells, but induce tolerance in antigen-specific and alloreactive responder cells.

Authors:  S Sidhu; S Deacock; V Bal; J R Batchelor; G Lombardi; R I Lechler
Journal:  J Exp Med       Date:  1992-09-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.